Castle Biosciences CSTL Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's deferred tax assets?
- Castle Biosciences (CSTL) reported deferred tax assets of $2.33M in Q1 2026.
- How has Castle Biosciences's deferred tax assets changed year-over-year?
- Castle Biosciences's deferred tax assets increased by 177.8% year-over-year, from $837K to $2.33M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.